Lupus Erythematosus, Cutaneous
"Lupus Erythematosus, Cutaneous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of lupus erythematosus in which the skin may be the only organ involved or in which skin involvement precedes the spread into other body systems. It has been classified into three forms - acute (= LUPUS ERYTHEMATOSUS, SYSTEMIC with skin lesions), subacute, and chronic (= LUPUS ERYTHEMATOSUS, DISCOID).
| Descriptor ID |
D008178
|
| MeSH Number(s) |
C17.300.475 C17.800.480
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Lupus Erythematosus, Cutaneous".
Below are MeSH descriptors whose meaning is more specific than "Lupus Erythematosus, Cutaneous".
This graph shows the total number of publications written about "Lupus Erythematosus, Cutaneous" by people in this website by year, and whether "Lupus Erythematosus, Cutaneous" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2017 | 4 | 0 | 4 |
| 2018 | 6 | 2 | 8 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 3 | 5 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Lupus Erythematosus, Cutaneous" by people in Profiles.
-
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination. Clin Exp Dermatol. 2022 Jan; 47(1):161-163.
-
Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine. Dermatol Ther. 2021 11; 34(6):e15114.
-
Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov; 35(11):e733-e735.
-
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine. Dermatol Ther. 2021 07; 34(4):e15017.
-
Untypical presentation of cutaneous lupus in a young patient following COVID-19: differentiation of COVID toes. Pol Arch Intern Med. 2021 08 30; 131(7-8):732-734.
-
Histological findings in chilblain lupus-like COVID lesions: in search of an answer to understand their aetiology. J Eur Acad Dermatol Venereol. 2020 Oct; 34(10):e572-e574.
-
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials. Travel Med Infect Dis. 2020 Jul - Aug; 36:101812.
-
New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus. J Am Acad Dermatol. 2020 Oct; 83(4):1219-1222.
-
Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy. Dermatol Ther. 2020 Jul; 33(4):e13776.
-
Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol. 2020 06 09; 60(1):32.